MEDICAL DEVICES FOR THERAPEUTIC AGENT DELIVERY

• US 20100028403A1
• Filed: 07/29/2009
• Published: 02/04/2010
• Est. Priority Date: 07/31/2008
• Status: Abandoned Application

• Current Assignee: Boston Scientific Scimed, Inc. (Boston Scientific Corporation)
• Original Assignee: Boston Scientific Scimed, Inc. (Boston Scientific Corporation)
• Inventors: Scheuermann, Torsten, Kuehling, Michael
• Application Number:
  US12/511,563
• Publication Number:
  US 20100028403A1
• Time in Patent Office: Days
• US Class Current: 424/423
• CPC Class Codes: A61L 2300/602 Type of release, e.g. controlled, sustained, slow
• CPC Class Codes: A61L 27/50 Materials characterised by their function or physical properties , e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
• CPC Class Codes: A61L 27/54 Biologically active materials, e.g. therapeutic substances A61L27/227 takes precedence
• CPC Class Codes: A61L 31/14 Materials characterised by their function or physical properties , e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
• CPC Class Codes: A61L 31/16 Biologically active materials, e.g. therapeutic substances A61L31/047 takes precedence

Abstract

In various aspects, the present invention relates to implantable or insertable medical devices which release therapeutic agent into the body of a patient.

Claims

1. A medical device comprising a substrate and a barrier layer, said substrate and said barrier layer at least partially defining an enclosed reservoir, said medical device further comprising a therapeutic agent and a crosslinked hydrophilic polymer disposed within the reservoir, wherein the reservoir is permeable to water such that, when the medical device is implanted in a patient, aqueous fluid enters the reservoir and swells the crosslinked hydrophilic polymer to a point where the barrier is burst.

2. The medical device of claim 1, wherein said substrate comprises a depression which defines at least a portion of said reservoir.

3. The medical device of claim 1, wherein said crosslinked hydrophilic polymer is selected from polyacrylic acid, polyethylene oxide, polyvinyl alcohol and gelatin.

4. The medical device of claim 1, wherein said barrier layer is an inorganic barrier layer.

5. The medical device of claim 1, wherein said barrier layer is permeable to aqueous fluid.

6. The medical device of claim 1, wherein the therapeutic agent is dispersed within the crosslinked hydrophilic polymer.

7. The medical device of claim 1, wherein the therapeutic agent is provided in a composition that is distinct from the crosslinked hydrophilic polymer.

8. The medical device of claim 1, wherein the medical device is selected from a stent, a stent graft, a pacemaker electrode, a neurostimulation implant, an infusion pump, a vascular access device, and an orthopedic implant.

9. A medical device comprising an enclosed reservoir that contains a therapeutic agent, wherein a release of the therapeutic agent from the reservoir into surrounding aqueous fluid is increased upon exposure to light, relative to the release that would otherwise occur in the absence of said exposure.

10. The medical device of claim 9, wherein said medical device comprises a substrate and a barrier layer, and wherein said substrate and said barrier layer at least partially define said enclosed reservoir.

11. The medical device of claim 10, wherein said substrate comprises a depression which at least partially defines said enclosed reservoir.

12. The medical device of claim 10, wherein said light is UV light.

13. The medical device of claim 12, wherein said barrier layer is a UV degradable barrier layer.

14. The medical device of claim 12, wherein said barrier layer is a UV degradable polymeric layer.

15. The medical device of claim 14, wherein said UV degradable polymeric layer comprises a photosensitizer.

16. The medical device of claim 12, wherein said barrier layer is transmissive to UV light and permeable to aqueous fluid, and wherein said reservoir comprises a polymer gel that is rendered susceptible to swelling in aqueous fluid upon exposure to UV light.

17. A medical device comprising a substrate and a barrier layer, said substrate and said barrier layer at least partially defining an enclosed reservoir, said medical device further comprising a therapeutic agent and a vaporizable liquid within the reservoir, wherein the vaporizable liquid is adjacent to a conductive material that can be heated to vaporize the vaporizable liquid and break the barrier layer by subjecting the conductive material to a magnetic field of suitable frequency and intensity.

18. The medical device of claim 17, wherein said substrate comprises a depression which defines at least a portion of said reservoir.

19. The medical device of claim 17, wherein the vaporizable liquid is selected from ethanol and acetone.